Tagged with cannabis

Global The global regulatory landscape for medical cannabis, showing the countries in which medical cannabis and cannabinoid treatments are legal / essentially legal, illegal but often unenforced, decriminalized, and illegal.   Made with Visme Infographic Maker   Click here to download our report on Canada’s world-leading medical cannabis industry

Cannabis One area in which the island nation of Malta has been a first mover in embracing disruption has been its controversial entry into the global cannabinoid market. The medical cannabis market within the EU is expected to be worth USD 56 billion by 2020 with leading European nations such as…

Cannabis While many Canadian medical cannabis outfits cover the entire value chain, from research and development through to manufacturing and distribution, others – such as Canopy Health and Tetra Bio-Pharma – are taking their cues from the biotechnology industry and strictly focusing on clinical trials.   I believe that across the…

Malta Marius Calleja, general manager of Maltese contract manufacturer, Starpharma, discusses the company’s current growth strategy and how Starpharma can capitalize on the emergent medical cannabis niche.       Even though you only started as general manager six months ago, can you describe the evolution of Starpharma over the years?…

Canada “If you are trying to be everything to everybody, you end up being nothing to no one”—Michael Gorenstein, CEO of The Cronos Group talks to PharmaBoardroom about his unusual career path, the company’s dual focus on medicinal and recreational cannabis, and how Canada will always remain the core center of…

Malta Paul Apap Bologna, managing director at Associated Drug Company (ADC), introduces his family company, focused on distributing high-quality innovative solutions to Maltese patients, and evokes the key opportunities that the medicinal cannabis segment can represent for Malta and the industry. Established in 1930, Associated Drug Company (ADC) has a long…

Malta Prof. Claude A. Farrugia of the Malta Chamber of Commerce, Enterprise and Industry documents the main trends in the manufacturing industry of Malta and discusses the island’s strengths in discovering new niches and exploiting opportunities as they present themselves. Farrugia also touches on the development of a biotech industry on…

Canada With already 20 percent of market share in the medical cannabis sector in Canada, MedReleaf is getting ready for the upcoming legalization of cannabis for recreational use. The company’s CEO Neil Closner also highlights MedReleaf’s important efforts in conducting R&D and clinical studies in order to present practitioners with relevant…

Canada Despite its relative youth, Canada’s medical cannabis industry is already presenting some of the characteristics of the much more mature pharmaceutical industry. There is consolidation as well as the first moves towards differentiating business models. “With medical cannabis, there is a chance to re-evaluate entirely the way we look at…

Canada Having just announced the first collaboration between a medical cannabis company and a major pharmaceutical player, Tilray expects to launch its first co-branded product with Sandoz Canada by the end of the year. Tilray’s founder and CEO Brendan Kennedy highlights the company’s main differentiation factors, including but not limited to…

Canada After 35 years in the pharmaceutical industry, Barry Fishman shares his excitement about heading one of Canada’s leading licensed cannabis producers. He explains how his experience in the world of pharma helps him to steer ABcann towards global expansion and emphasizes the importance of product development in both adult-use and…

Canada With a diverse pipeline to back up its projects, Tetra Bio-Pharma wants to be the first Canadian pharmaceutical company to launch a cannabis-based drug in breakthrough pain. Bernard Fortier, CEO of Tetra Bio-Pharma, counts on the production of credible scientific data to overcome stigmas attached to medical cannabis and believes…